Cambridge Healthtech Institute and Bio-IT World’s Inaugural
RNA-Seq and Transcriptome Analysis
Part of the Fifth International Clinical Genomics & Informatics Europe event
5-6 December 2013 | Sheraton Lisbon Hotel & Spa | Lisbon, Portugal
Transcriptome sequencing (RNA-Seq) is a robust approach steadily replacing microarrays as the choice method to accurately profile and quantify overall gene expression levels, while simultaneously allowing unbiased discovery of alternative splicing variants, rare and novel transcripts, miRNA precursors, differential isoforms and de novo analysis of samples. The ability to obtain a complete picture of disease transcriptomes provides clearer understanding of how the underlying genome is converted into the functional proteins, allowing for clinical utility in patient classification, diagnosis, and individualized treatment. However, a myriad of advanced bioinformatics tools and techniques for quality control, pre-processing, alignment, quantitative analysis and differential expression pose significant hurdles for many biologists and clinicians. Cambridge Healthtech Institute and Bio-IT World’s RNA-Seq and Transcriptome Analysis is designed to navigate the many bioinformatics challenges encountered by transcriptome sequencing, while highlighting its recent clinical applications.
Topics may include but are not limited to:
- Application-Specific RNA-Seq vs. Microarrays
- RNA-Seq from FFPE or Small-Volume Samples
- Sample Preparation
- Identification of Characterization of miRNAs, lncRNAs, and other non-coding RNAs
- Single Cell Transcriptome Sequencing
- Patient Classification and Gene Expression-Based Biomarkers
- Gene Fusion Detection
- Bioinformatics Tools for RNA-Seq
- Quantitative Analysis and Differential Expression
- Transcriptome de novo Assembly
- Transcriptome Annotation
- Genome Annotation with RNA-Seq
- RNA Editing and Methylation
If you are interested in presenting, please click here to submit a speaking proposal for review. Please note that due to limited speaking slots, preference is given to abstracts from those within academic centers, pharmaceutical and biotech companies, and regulators. Additionally, per CHI policy, a select number of vendors/consultants who provide products and services to the audience are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality conference program.
Deadline for submission is 24 May 2013.
We truly welcome your comments, suggestions and speaker referrals as we shape the 2013 program.
For questions or suggestions about the meeting, please contact:
For exhibit and sponsorship opportunities for companies A-K:
Business Development Manager
For exhibit and sponsorship opportunities for companies L-Z:
Business Development Manager
For marketing and media partnerships, please contact:
Kaushik (KC) Chaudhuri
Director of Product Marketing
Associate Marketing Manager